ULTRALIFE Files 8-K for Financial Results on Feb 15, 2024
Ticker: ULBI · Form: 8-K · Filed: Feb 15, 2024 · CIK: 875657
| Field | Detail |
|---|---|
| Company | Ultralife Corp (ULBI) |
| Form Type | 8-K |
| Filed Date | Feb 15, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting, disclosure
Related Tickers: ULBI
TL;DR
**ULBI filed an 8-K on Feb 15, 2024, for financial results; details not in this snippet.**
AI Summary
ULTRALIFE CORPORATION (ULBI) filed an 8-K on February 15, 2024, reporting on 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'. The filing indicates that the earliest event reported also occurred on February 15, 2024. This administrative filing confirms the company's reporting of its financial performance.
Why It Matters
This 8-K signals that ULTRALIFE CORPORATION is reporting its financial performance, which is crucial for investors to understand the company's health and future prospects. While the specific results are not detailed in this snippet, the filing itself is a standard disclosure.
Risk Assessment
Risk Level: low — This filing is purely administrative, announcing the reporting of financial results, and contains no specific information that would inherently increase or decrease risk.
Key Numbers
- February 15, 2024 — Date of Report (Earliest event reported date for the 8-K filing.)
- 000-20852 — SEC File Number (ULTRALIFE CORPORATION's SEC file number.)
- 315-332-7100 — Business Phone (Registrant's telephone number.)
Key Players & Entities
- ULTRALIFE CORPORATION (company) — registrant
- ULTRALIFE CORP (company) — company name
- ULTRALIFE BATTERIES INC (company) — former company name
- February 15, 2024 (date) — date of report
- Delaware (location) — state of incorporation
- Newark, New York (location) — principal executive offices
- $0.10 (dollar_amount) — par value per share
FAQ
What is the accession number for this 8-K filing?
The accession number for this 8-K filing is 0001437749-24-004266.
What is the full legal name of the registrant filing this 8-K?
The full legal name of the registrant is ULTRALIFE CORPORATION.
What items are reported in this 8-K filing?
This 8-K reports on 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.
When was the earliest event reported in this 8-K?
The earliest event reported in this 8-K occurred on February 15, 2024.
What is the ticker symbol for ULTRALIFE CORPORATION's common stock?
The ticker symbol for ULTRALIFE CORPORATION's common stock is ULBI on NASDAQ.
Filing Stats: 421 words · 2 min read · ~1 pages · Grade level 12.2 · Accepted 2024-02-15 07:30:29
Key Financial Figures
- $0.10 — ction 12(b) of the Act: Common Stock , $0.10 par value per share ULBI NASDAQ (
Filing Documents
- ulbi20240214_8k.htm (8-K) — 22KB
- ex_626948.htm (EX-99.1) — 285KB
- ex_626948img001.jpg (GRAPHIC) — 3KB
- 0001437749-24-004266.txt ( ) — 458KB
- ulbi-20240215.xsd (EX-101.SCH) — 3KB
- ulbi-20240215_def.xml (EX-101.DEF) — 11KB
- ulbi-20240215_lab.xml (EX-101.LAB) — 15KB
- ulbi-20240215_pre.xml (EX-101.PRE) — 11KB
- ulbi20240214_8k_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition On February 15, 2024, Ultralife Corporation issued a press release regarding the financial results for its fourth quarter and full year ended December 31, 2023. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by this reference.
01 Financial Statements, Pro Forma Financials and Exhibits
Item 9.01 Financial Statements, Pro Forma Financials and Exhibits (d) Exhibits. Exhibit Number Exhibit Description 99.1 Press Release of Ultralife Corporation dated February 15, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 15, 2024 ULTRALIFE CORPORATION By: /s/ Philip A. Fain Philip A. Fain Chief Financial Officer and Treasurer